SynthesisPloS one2023

Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.

What the trial testedas reported · 2023

Range includes no effect

1.1×0.4× to 3.1×

Bigger than 3 in 10 for all-cause mortality

As reported

HR 1.10, 95% CI 0.38–3.15 · the paper's word: All-cause mortality

the abstract, start to end

… whereas the pooled adjusted HR was 1.10 (95% CI, 0.38-3.15).

← favours treatmentfavours comparator →

could be chance

All-cause mortality

HR 1.100.38–3.15

MetforminAll-cause mortality

1 / 3

2023

2024

2025

2026

this paperpooled itcites it